AYTU BIOPHARMA, INC Earnings Per Share (Basic)
AYTU BIOPHARMA, INC (AYTU) reported Earnings Per Share (Basic) of -$1.16 per share for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-09-22
- AYTU BIOPHARMA, INC earnings per share, basic for the quarter ending 2026-03-31 was -$0.53, a 181.54% decline year-over-year.
- AYTU BIOPHARMA, INC earnings per share, basic for the quarter ending 2025-12-31 was -$1.05, a 907.69% decline year-over-year.
- AYTU BIOPHARMA, INC earnings per share, basic for the quarter ending 2025-09-30 was $0.21, a 12.50% decline year-over-year.
- AYTU BIOPHARMA, INC earnings per share, basic for the quarter ending 2025-03-31 was $0.65.
- AYTU BIOPHARMA, INC earnings per share, basic for fiscal 2026 was -$1.16.
- AYTU BIOPHARMA, INC earnings per share, basic for fiscal 2025 was -$2.16.
- AYTU BIOPHARMA, INC earnings per share, basic for fiscal 2024 was -$2.86.
- AYTU BIOPHARMA, INC earnings per share, basic for fiscal 2023 was -$5.11.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.16 10-K · filed 2026-09-22 | |||||||
| 2026-03-31 | -$0.53 10-Q · filed 2026-05-13 | -$1.58 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$1.42 10-Q · filed 2026-05-13 | |||||
| 2025-12-31 | -$1.05 10-Q · filed 2026-02-03 | -$0.89 10-Q · filed 2026-02-03 | ||||||
| 2025-09-30 | $0.21 10-Q · filed 2025-11-13 | |||||||
| 2025-06-30 | -$2.16 10-K · filed 2026-09-22 | |||||||
| 2025-03-31 | $0.65 10-Q · filed 2026-05-13 | $0.78 derived: net income ÷ weighted average shares · filed 2026-05-13 | $1.02 10-Q · filed 2026-05-13 | |||||
| 2024-12-31 | $0.13 10-Q · filed 2026-02-03 | $0.37 10-Q · filed 2026-02-03 | ||||||
| 2024-09-30 | $0.24 10-Q · filed 2025-11-13 | |||||||
| 2024-06-30 | -$2.86 10-K · filed 2025-09-23 | |||||||
| 2024-03-31 | -$0.52 10-Q · filed 2025-05-14 | -$0.56 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$2.04 10-Q · filed 2025-05-14 | |||||
| 2023-12-31 | -$0.04 10-Q · filed 2025-02-12 | -$1.52 10-Q · filed 2025-02-12 | ||||||
| 2023-09-30 | -$1.48 10-Q · filed 2024-11-13 | |||||||
| 2023-06-30 | -$5.11 10-K · filed 2024-09-26 | |||||||
| 2023-03-31 | -$1.93 10-Q · filed 2024-05-15 | -$4.71 10-Q · filed 2024-05-15 | ||||||
| 2022-12-31 | -$2.15 10-Q · filed 2024-02-14 | -$2.62 10-Q · filed 2024-02-14 | ||||||
| 2022-09-30 | -$0.28 10-Q · filed 2023-11-14 | -$0.06 10-Q · filed 2022-11-14 | ||||||
| 2022-06-30 | -$74.01 10-K · filed 2023-10-12 | -$3.39 10-K · filed 2022-09-27 | ||||||
| 2022-03-31 | -$35.90 10-Q · filed 2023-05-11 | -$1.79 10-Q · filed 2022-05-16 | -$68.13 10-Q · filed 2023-05-11 | -$3.40 10-Q · filed 2022-05-16 | ||||
| 2021-12-31 | -$8.74 10-Q · filed 2023-02-21 | -$0.44 10-Q · filed 2022-02-14 | -$30.30 10-Q · filed 2023-02-21 | -$1.52 10-Q · filed 2022-02-14 | ||||
| 2021-09-30 | -$21.76 10-Q/A · filed 2023-02-21 | -$1.09 10-Q · filed 2021-11-15 | ||||||
| 2021-06-30 | -$3.48 10-K · filed 2022-09-27 | |||||||
| 2021-03-31 | -$1.41 10-Q · filed 2022-05-16 | -$2.71 10-Q · filed 2022-05-16 | ||||||
| 2020-12-31 | -$0.72 10-Q · filed 2022-02-14 | -$1.09 10-Q · filed 2022-02-14 | ||||||
| 2020-09-30 | -$0.35 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |